Granisetron
Sancuso, Sustol (granisetron) is a small molecule pharmaceutical. Granisetron was first approved as Sancuso on 2008-09-12. It has been approved in Europe to treat neoplasms and vomiting. Granisetron hydrochloride's patents are valid until 2025-01-22 (FDA).
| Trade Name | Sancuso |
|---|---|
| Common Name | Granisetron |
| Indication | neoplasms, vomiting |
| Drug Class | Serotonin 5-HT3 antagonists |
